CALR del52 was detected by GeneScan fragment size analysis in CD34+ cells with a similar VAF (51%) as those from the chronic phase, while in CD3+ cells, the MPN driver mutation was present at a lower VAF (24.3%). Here, CALR is linked to myeloproliferative neoplasm.